China Resources Double Crane Unit Wins First Domestic Acute Mountain Sickness Drug Approval

China Resources Double Crane announced on August 11 that its controlling subsidiary Henan Zhongshuai Pharmaceutical Technology Co. , Ltd. received a Drug Registration Certificate from the National Medical Products Administration for acetazolamide extended-release capsules. Under relevant national policies, the certificate is deemed equivalent to passing the generic drug consistency evaluation. The drug is the first domestically approved product for preventing or improving acute mountain sickness.